Centerstone’s Ketamine/Esketamine Program for Treatment-Resistant Depression featured on news broadcast

Centerstone’s new therapy program for individuals seeking treatment for severe depression was featured recently on WFLA-TV.

Through the program, Centerstone can offer Spravato, a nasal spray that contains the FDA-approved medication Esketamine, and ketamine infusion therapy for people who have been treated for depression with no improvement in symptoms.

To learn more about this program, please go online to centerstone.org/esketamine. To view this video, please click here.

Location Finder

Related Posts

Centerstone partnering with MDsave to offer alternative payments arrangements at its Bradenton, Fla. hospital

Press Release
Bradenton, Fla. — Centerstone is working to address this barrier by offering alternative payment arrangements for in-patient addiction treatment ...


Centerstone produces video to highlight ObservSMART patient-monitoring system

Press Release
Centerstone has produced a new video all about ObservSMART, a proximity-based monitoring system that has been added to its ...


Centerstone Launches New Treatment Therapies for Depression

Mental Health
Press Release
Centerstone, a national leader in behavioral health care, has introduced new therapies for individuals seeking treatment for severe depression. ...

depression Treatment Esketamine

Kathryn Graber Honored as Child Advocate of the Year

Family Matters
Press Release
Centerstone’s Kathryn Graber was recently honored by Manatee Children’s Services as the James Wischer Child Advocate of the Year! ...


Roger Johnson Named COO in Florida

Press Release
Centerstone has announced the promotion of Roger Johnson to chief operating officer in Florida. Johnson previously served as regional ...


Call Now

photo of
44 Vantage Way
Nashville, TN, 37228 United States